BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 22787121)

  • 1. ATP-citrate lyase: a key player in cancer metabolism.
    Zaidi N; Swinnen JV; Smans K
    Cancer Res; 2012 Aug; 72(15):3709-14. PubMed ID: 22787121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-citrate lyase: a mini-review.
    Chypre M; Zaidi N; Smans K
    Biochem Biophys Res Commun; 2012 May; 422(1):1-4. PubMed ID: 22575446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
    Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
    FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
    Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
    Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
    Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
    Granchi C
    Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
    Zheng W; Tasselli L; Li TM; Chua KF
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes.
    Chen LY; Lotz M; Terkeltaub R; Liu-Bryan R
    J Biol Chem; 2018 Aug; 293(31):12259-12270. PubMed ID: 29929979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
    Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
    Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP citrate lyase: A central metabolic enzyme in cancer.
    Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
    Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of ATP-Citrate Lyase in the Immune System.
    Dominguez M; Brüne B; Namgaladze D
    Front Immunol; 2021; 12():632526. PubMed ID: 33679780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
    Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
    Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
    Burke AC; Huff MW
    Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP citrate lyase mediated cytosolic acetyl-CoA biosynthesis increases mevalonate production in Saccharomyces cerevisiae.
    Rodriguez S; Denby CM; Van Vu T; Baidoo EE; Wang G; Keasling JD
    Microb Cell Fact; 2016 Mar; 15():48. PubMed ID: 26939608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.
    Sivanand S; Rhoades S; Jiang Q; Lee JV; Benci J; Zhang J; Yuan S; Viney I; Zhao S; Carrer A; Bennett MJ; Minn AJ; Weljie AM; Greenberg RA; Wellen KE
    Mol Cell; 2017 Jul; 67(2):252-265.e6. PubMed ID: 28689661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
    Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
    Front Immunol; 2018; 9():2858. PubMed ID: 30568658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
    Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y
    Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective.
    Granchi C
    Expert Opin Ther Pat; 2022 Jul; 32(7):731-742. PubMed ID: 35436171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
    Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
    Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.